Arbutus Biopharma Corp Operating Expenses
Arbutus Biopharma Corp (ABUS) reported Operating Expenses of $6.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-12
CAD
| Period end | Operating Expenses 12 month |
|---|---|
| 2012-12-31 | 27.03M CAD 20-F · filed 2013-03-27 |
| 2011-12-31 | 27.19M CAD 20-F · filed 2013-03-27 |
| 2010-12-31 | 33.87M CAD 20-F · filed 2013-03-27 |
| 2009-12-31 | 22.91M CAD 20-F · filed 2012-03-27 |
USD
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.98M 10-Q · filed 2026-08-12 | $17.20M 10-Q · filed 2026-08-12 | $23.54M derived: sum of 3 quarters · filed 2026-08-12 | $32.73M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $10.22M 10-Q · filed 2026-05-13 | $16.56M derived: sum of 2 quarters · filed 2026-05-13 | $25.75M derived: sum of 3 quarters · filed 2026-05-13 | $35.00M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $15.53M derived: sum of 2 quarters · filed 2026-03-23 | $24.78M derived: sum of 3 quarters · filed 2026-08-12 | $52.24M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $9.19M 10-Q · filed 2025-11-13 | $18.44M derived: sum of 2 quarters · filed 2026-08-12 | $45.90M 10-Q · filed 2025-11-13 | $61.41M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $9.25M 10-Q · filed 2026-08-12 | $36.71M 10-Q · filed 2026-08-12 | $52.22M derived: sum of 3 quarters · filed 2026-08-12 | $75.00M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $27.46M 10-Q · filed 2026-05-13 | $42.97M derived: sum of 2 quarters · filed 2026-05-13 | $65.75M derived: sum of 3 quarters · filed 2026-05-13 | $89.06M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $15.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $38.29M derived: sum of 2 quarters · filed 2026-03-23 | $61.59M derived: sum of 3 quarters · filed 2026-03-23 | $82.49M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $22.78M 10-Q · filed 2025-11-13 | $46.09M derived: sum of 2 quarters · filed 2025-11-13 | $66.98M 10-Q · filed 2025-11-13 | $89.88M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $23.31M 10-Q · filed 2025-08-06 | $44.20M 10-Q · filed 2025-08-06 | $67.10M derived: sum of 3 quarters · filed 2025-08-06 | $93.31M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $20.89M 10-Q · filed 2025-05-14 | $43.79M derived: sum of 2 quarters · filed 2025-05-14 | $70.00M derived: sum of 3 quarters · filed 2025-05-14 | $93.04M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $22.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $49.11M derived: sum of 2 quarters · filed 2025-03-27 | $72.14M derived: sum of 3 quarters · filed 2025-03-27 | $96.24M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $26.22M 10-Q · filed 2024-11-06 | $49.25M derived: sum of 2 quarters · filed 2024-11-06 | $73.35M 10-Q · filed 2024-11-06 | $102.16M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $23.04M 10-Q · filed 2024-08-08 | $47.14M 10-Q · filed 2024-08-08 | $75.94M derived: sum of 3 quarters · filed 2024-08-08 | $99.71M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $24.10M 10-Q · filed 2024-05-02 | $52.91M derived: sum of 2 quarters · filed 2024-05-02 | $76.67M derived: sum of 3 quarters · filed 2024-05-02 | $105.02M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $28.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $52.57M derived: sum of 2 quarters · filed 2024-03-05 | $80.92M derived: sum of 3 quarters · filed 2024-03-05 | $104.47M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | $23.76M 10-Q · filed 2023-11-07 | $52.11M derived: sum of 2 quarters · filed 2023-11-07 | $75.67M 10-Q · filed 2023-11-07 | $99.67M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $28.35M 10-Q · filed 2023-08-03 | $51.91M 10-Q · filed 2023-08-03 | $75.91M derived: sum of 3 quarters · filed 2023-08-03 | $97.66M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $23.55M 10-Q · filed 2023-05-04 | $47.56M derived: sum of 2 quarters · filed 2023-05-04 | $69.31M derived: sum of 3 quarters · filed 2023-05-04 | $90.28M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $45.75M derived: sum of 2 quarters · filed 2023-03-02 | $66.72M derived: sum of 3 quarters · filed 2023-03-02 | $84.51M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $21.75M 10-Q · filed 2022-11-09 | $42.72M derived: sum of 2 quarters · filed 2022-11-09 | $60.51M 10-Q · filed 2022-11-09 | $79.19M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $20.97M 10-Q · filed 2022-08-04 | $38.76M 10-Q · filed 2022-08-04 | $57.45M derived: sum of 3 quarters · filed 2022-08-04 | $74.19M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $17.79M 10-Q · filed 2022-05-05 | $36.48M derived: sum of 2 quarters · filed 2022-05-05 | $53.22M derived: sum of 3 quarters · filed 2022-05-05 | $67.87M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $18.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $35.43M derived: sum of 2 quarters · filed 2022-03-03 | $50.08M derived: sum of 3 quarters · filed 2022-03-03 | $64.72M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | $16.74M 10-Q · filed 2021-11-04 | $31.39M derived: sum of 2 quarters · filed 2021-11-04 | $46.03M 10-Q · filed 2021-11-04 | $60.69M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $14.65M 10-Q · filed 2021-08-05 | $29.29M 10-Q · filed 2021-08-05 | $43.95M derived: sum of 3 quarters · filed 2021-08-05 | $138.03M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $14.64M 10-Q · filed 2021-05-05 | $29.29M derived: sum of 2 quarters · filed 2021-05-05 | $123.38M derived: sum of 3 quarters · filed 2021-05-05 | $144.68M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $14.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $108.74M derived: sum of 2 quarters · filed 2021-03-04 | $130.04M derived: sum of 3 quarters · filed 2021-03-04 | $149.91M 10-K · filed 2021-03-04 | $150.09M 10-K · filed 2020-03-05 | |||
| 2019-09-30 | $94.09M 10-Q · filed 2020-11-05 | $94.46M 10-Q · filed 2019-11-06 | $115.38M derived: sum of 2 quarters · filed 2020-11-05 | $135.26M 10-Q · filed 2020-11-05 | $135.38M 10-Q · filed 2019-11-06 | $153.84M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $21.30M 10-Q · filed 2020-08-07 | $21.17M 10-Q · filed 2019-08-05 | $41.17M 10-Q · filed 2020-08-07 | $40.92M 10-Q · filed 2019-08-05 | $59.75M derived: sum of 3 quarters · filed 2020-08-07 | $93.77M derived: sum of 4 quarters · filed 2020-08-07 | ||
| 2019-03-31 | $19.88M 10-Q · filed 2020-05-11 | $19.75M 10-Q · filed 2019-05-06 | $38.46M derived: sum of 2 quarters · filed 2020-05-11 | $72.47M derived: sum of 3 quarters · filed 2020-05-11 | $95.76M derived: sum of 4 quarters · filed 2020-05-11 | |||
| 2018-12-31 | $18.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $52.59M derived: sum of 2 quarters · filed 2020-03-05 | $75.88M derived: sum of 3 quarters · filed 2020-03-05 | $95.72M 10-K · filed 2020-03-05 | ||||
| 2018-09-30 | $34.01M 10-Q · filed 2019-11-06 | $57.30M derived: sum of 2 quarters · filed 2019-11-06 | $77.14M 10-Q · filed 2019-11-06 | $139.93M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | $23.29M 10-Q · filed 2019-08-05 | $43.13M 10-Q · filed 2019-08-05 | $105.91M derived: sum of 3 quarters · filed 2019-08-05 | $125.70M derived: sum of 4 quarters · filed 2019-08-05 | ||||
| 2018-03-31 | $19.84M 10-Q · filed 2019-05-06 | $82.62M derived: sum of 2 quarters · filed 2019-05-06 | $102.41M derived: sum of 3 quarters · filed 2019-05-06 | $122.94M derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | $62.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $82.57M derived: sum of 2 quarters · filed 2019-03-07 | $103.10M derived: sum of 3 quarters · filed 2019-03-07 | $121.63M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | $19.79M 10-Q · filed 2018-11-07 | $40.31M derived: sum of 2 quarters · filed 2018-11-07 | $58.85M 10-Q · filed 2018-11-07 | $316.09M derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $20.52M 10-Q · filed 2018-08-03 | $39.06M 10-Q · filed 2018-08-03 | $296.30M derived: sum of 3 quarters · filed 2018-08-03 | $316.05M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | $18.53M 10-Q · filed 2018-05-04 | $275.78M derived: sum of 2 quarters · filed 2018-05-04 | $295.53M derived: sum of 3 quarters · filed 2018-05-04 | $491.08M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2016-12-31 | $257.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $276.99M derived: sum of 2 quarters · filed 2018-03-16 | $472.55M derived: sum of 3 quarters · filed 2018-03-16 | $493.13M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $19.75M 10-Q · filed 2017-11-02 | $215.31M derived: sum of 2 quarters · filed 2017-11-02 | $235.89M 10-Q · filed 2017-11-02 | $260.33M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $195.56M 10-Q · filed 2017-08-03 | $216.14M 10-Q · filed 2017-08-03 | $240.58M derived: sum of 3 quarters · filed 2018-03-16 | $302.78M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $20.58M 10-Q · filed 2017-05-04 | $45.02M derived: sum of 2 quarters · filed 2018-03-16 | $107.23M derived: sum of 3 quarters · filed 2018-03-16 | $125.09M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $86.65M derived: sum of 2 quarters · filed 2018-03-16 | $104.51M derived: sum of 3 quarters · filed 2018-03-16 | $127.19M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $62.20M 10-Q · filed 2016-11-03 | $80.06M derived: sum of 2 quarters · filed 2016-11-03 | $102.75M 10-Q · filed 2016-11-03 | $118.31M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-06-30 | $17.86M 10-Q · filed 2016-08-04 | $40.55M 10-Q · filed 2016-08-04 | $56.11M derived: sum of 3 quarters · filed 2017-03-22 | $67.31M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2015-03-31 | $22.69M 10-Q · filed 2016-05-04 | $38.25M derived: sum of 2 quarters · filed 2017-03-22 | $49.45M derived: sum of 3 quarters · filed 2017-03-22 | $60.69M derived: sum of 4 quarters · filed 2017-03-22 | ||||
| 2014-12-31 | $15.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $26.77M derived: sum of 2 quarters · filed 2017-03-22 | $38.00M derived: sum of 3 quarters · filed 2017-03-22 | $48.39M 10-K · filed 2017-03-22 | $47.92M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $11.21M 10-Q · filed 2015-11-05 | $22.44M derived: sum of 2 quarters · filed 2015-11-05 | $32.83M 10-Q · filed 2015-11-05 | $42.79M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-06-30 | $11.23M 10-Q · filed 2015-08-07 | $21.62M 10-Q · filed 2015-08-07 | $31.59M derived: sum of 3 quarters · filed 2016-03-09 | $38.20M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-03-31 | $10.39M 10-Q · filed 2015-05-06 | $20.35M derived: sum of 2 quarters · filed 2016-03-09 | $26.96M derived: sum of 3 quarters · filed 2016-03-09 | $32.88M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2013-12-31 | $9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $16.58M derived: sum of 2 quarters · filed 2016-03-09 | $22.49M derived: sum of 3 quarters · filed 2016-03-09 | $27.62M 10-K · filed 2016-03-09 | $27.62M 6-K · filed 2014-03-06 | |||
| 2013-09-30 | $6.61M 10-Q · filed 2014-11-07 | $12.53M derived: sum of 2 quarters · filed 2014-11-07 | $17.65M 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | $5.92M 10-Q · filed 2014-08-14 | $11.04M 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | $5.13M 10-Q · filed 2014-05-14 | |||||||
| 2012-12-31 | $27.05M 10-K · filed 2015-03-13 | $27.05M 6-K · filed 2014-03-06 | ||||||
| 2011-12-31 | $27.51M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |